| ABCB1 | ATP-Binding Cassette Subfamily B Member 1 |
| AD | Alzheimer’s Disease |
| ADHD | Attention-Deficit/Hyperactivity Disorder |
| AES | Apathy Evaluation Scale |
| APA | American Psychological Association |
| BA | Behavioral Activation |
| BBB | Blood–Brain Barrier |
| BDI | Beck Depression Inventory |
| BDNF | Brain-Derived Neurotrophic Factor |
| BMI | Body Mass Index |
| CBT | Cognitive Behavioral Therapy |
| CESD-10 | Center for Epidemiologic Studies Depression Scale (10-item version) |
| CNS | Central Nervous System |
| CRP | C-Reactive Protein |
| CSF | Cerebrospinal Fluid |
| CSVD | Cerebral Small Vessel Disease |
| CYP2C19 | Cytochrome P450 2C19 |
| CYP2D6 | Cytochrome P450 2D6 |
| CYP450 | Cytochrome P450 |
| DAMPs | Damage-Associated Molecular Patterns |
| DLPFC | Dorsolateral Prefrontal Cortex |
| DSM-5 | Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition |
| dTMS | Deep Transcranial Magnetic Stimulation |
| ECT | Electroconvulsive Therapy |
| EOD | Early-Onset Depression |
| ESC/MEM | Escitalopram + Memantine |
| FDA | U.S. Food and Drug Administration |
| FTD | Frontotemporal Dementia |
| GDS | Geriatric Depression Scale |
| HAM-D | Hamilton Depression Rating Scale |
| HDRS | Hamilton Depression Rating Scale |
| HDRS-21 | 21-item Hamilton Depression Rating Scale |
| HPA | Hypothalamic–Pituitary–Adrenal (axis) |
| HTR2A | 5-Hydroxytryptamine (Serotonin) Receptor 2A Gene |
| IADL | Instrumental Activities of Daily Living |
| IL-6 | Interleukin-6 |
| IPT | Interpersonal Therapy |
| LLD | Late-Life Depression |
| LOD | Late-Onset Depression |
| MADRS | Montgomery–Åsberg Depression Rating Scale |
| MDD | Major Depressive Disorder |
| MDE | Major Depressive Episode |
| MEM | Memantine |
| MRI | Magnetic Resonance Imaging |
| MT | Motor Threshold |
| NDRI | Norepinephrine–Dopamine Reuptake Inhibitor |
| NMDA | N-Methyl-D-Aspartate |
| NLRP3 | NOD-, LRR-, and Pyrin Domain-Containing Protein 3 |
| NSAIDs | Nonsteroidal Anti-Inflammatory Drugs |
| OMEGA-3 | Omega-3 Polyunsaturated Fatty Acids |
| PET | Positron Emission Tomography |
| PROSPECT | Prevention of Suicide in Primary Care Elderly: Collaborative Trial |
| RCT | Randomized Controlled Trial |
| ROS | Reactive Oxygen Species |
| rTMS | Repetitive Transcranial Magnetic Stimulation |
| SLC6A4 | Solute Carrier Family 6 Member 4 (Serotonin Transporter Gene) |
| SNRI | Serotonin–Norepinephrine Reuptake Inhibitor |
| SSRI | Selective Serotonin Reuptake Inhibitor |
| TMS | Transcranial Magnetic Stimulation |
| TNF-α | Tumor Necrosis Factor-Alpha |
| TRD | Treatment-Resistant Depression |
| TR-LOD | Treatment-Resistant Late-Onset Depression |
| WMH | White Matter Hyperintensities |